Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational studyFrancesca Sofia Di Lisa, Enzo Veltri, Eriseld Krasniqi et al.|Frontiers in Oncology|2023Cited by 9
Supplementary Video 2 from The Heterochronic microRNA <i>let-7</i> Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast CancerXiaowen Hu, Lin Zhang, Qihong Huang et al.|Unknown|2023Cited by 0
Supplementary Tables 1 - 2 from The Heterochronic microRNA <i>let-7</i> Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast CancerXiaowen Hu, Lin Zhang, Jinyi Guo et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from The Heterochronic microRNA <i>let-7</i> Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast CancerXiaowen Hu, Lin Zhang, Jinyi Guo et al.|Unknown|2023Cited by 0
Supplementary Tables 1 - 2 from The Heterochronic microRNA <i>let-7</i> Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast CancerXiaowen Hu, Lin Zhang, Jinyi Guo et al.|Unknown|2023Cited by 0